Development of a Preclinical NF1-MPNST Platform Suitable for Precision Oncology Drug Discovery and Evaluation

Tech ID: T-019044

This technology contains a set of patient derived xenograft cell lines. These cell lines represent the heterogeneity of human malignant peripheral nerve sheath tumors (MPNSTs) that can be used to test novel agents to move forward into clinical trials.

Categories

No items found

Inventors

Contact

Zou, Dianxiong

dzou@wustl.edu

Create a Collection
Creating...